Robert Williams
Internal Medicine · Tracy, CANPI 1184682254
Payments from drug & device makers
Across 122 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$470
- Boehringer Ingelheim$412
- GSK$345
- Teva Pharmaceuticals USA, Inc.$227
- Amgen$149
- Kowa Pharmaceuticals America, Inc.$101
- plus $682 from 17 others
What the payments were for
- Food & beverage$2,386100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $470 |
| Boehringer Ingelheim | 21 | $412 |
| GSK | 17 | $345 |
| Teva Pharmaceuticals USA, Inc. | 12 | $227 |
| Amgen | 7 | $149 |
| Kowa Pharmaceuticals America, Inc. | 6 | $101 |
| Novo Nordisk | 5 | $89 |
| E.r. Squibb & Sons, L.L.C. | 5 | $84 |
| Johnson & Johnson | 5 | $83 |
| Pfizer | 5 | $77 |
| Shire North American Group Inc | 2 | $44 |
| Lilly USA, LLC | 3 | $41 |
| Amarin Pharma, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 3 | $36 |
| Smith+Nephew | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Merck | 2 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$125
- CINQAIR$125
- TRELEGY ELLIPTA$125
- NUCALA$125
- FARXIGA$125
How this compares
$2,386 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tracy
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.